Sensory Processing and Gastrointestinal Manifestations in Autism Spectrum Disorders: No Relation to Clostridium...

Area of Science:

• Microbiology
• Neurodevelopmental Disorders
• Gastroenterology

Background:

• The gut microbiota's role in autism spectrum disorders (ASD) is under investigation due to frequent gastrointestinal (GI) symptoms in affected children.
• Previous research has suggested the presence of pathogenic gut bacteria in children with ASD.
• Clostridium difficile (C. difficile) is a bacterium known to cause GI issues.

Purpose of the Study:

• To investigate the prevalence of Clostridium difficile in the stool of children with ASD.
• To examine the relationship between C. difficile presence and GI comorbidities, autism severity, and sensory impairment in ASD.
• To assess the toxin production of C. difficile strains found in ASD cases and control groups.

Main Methods:

• Study included 58 children with ASD, 45 neurotypical siblings, and 45 unrelated controls.
• Autism severity was assessed using the Childhood Autism Rating Scale (CARS).
• Sensory problems were evaluated using the Short Sensory Profile (SSP).
• GI symptoms were assessed using a modified six-item GI Severity Index (6-GSI).
• Quantitative real-time PCR was used to detect and quantify C. difficile and its toxins A and B.

Main Results:

• C. difficile was detected in 25.9% of ASD cases, 40% of siblings, and 15.6% of controls.
• A high percentage of detected C. difficile strains were toxigenic across all groups (73.3% in ASD, 77.8% in siblings, 71.4% in controls).
• No statistically significant differences were found between the groups regarding C. difficile prevalence, quantity, or toxin production.
• No significant association was found between C. difficile and GI Severity Index in ASD cases.

Conclusions:

• Clostridium difficile is not specifically more prevalent in the gut of children with ASD compared to neurotypical siblings and unrelated controls.
• Although most identified C. difficile strains were toxigenic, their presence did not correlate with GI symptoms in controls or significantly with GI severity in ASD cases.
• Gastrointestinal dysfunction and sensory impairment remain common comorbidities in ASD, but C. difficile does not appear to be a primary driver in this cohort.